Schrödinger to Announce Fourth Quarter and Full-Year 2022 Financial Results on February 28

Rhea-AI Summary

Schrödinger (Nasdaq: SDGR) will announce its fourth quarter and full-year 2022 financial results on February 28, 2023, after market close. A conference call and webcast will follow at 4:30 p.m. ET. Interested participants can access the live webcast under 'News & Events' on Schrödinger's investor website. The company leverages its physics-based computational platform to revolutionize drug and material discoveries, with partnerships worldwide. Founded in 1990, Schrödinger employs over 800 staff and collaborates in more than 70 countries.

Positive

• Schrödinger's physics-based computational platform enables faster and cost-effective drug and material discovery.
• The company is involved with customers and collaborators in over 70 countries.

Negative

• None.

NEW YORK--(BUSINESS WIRE)-- Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, will report its fourth quarter and full-year 2022 financial results on Tuesday, February 28, 2023, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET.

The live webcast can be accessed under "News & Events" in the investors section of Schrödinger’s website, https://ir.schrodinger.com/news-and-events/event-calendar. To participate in the live call, please register for the call here. It is recommended that participants register at least 15 minutes in advance of the call. Once registered, participants will receive the dial-in information. The archived webcast will be available on Schrödinger’s website for approximately 90 days following the event.

About Schrödinger
Schrödinger is transforming the way therapeutics and materials are discovered. Schrödinger has pioneered a physics-based computational platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. The software platform is licensed by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Schrödinger’s multidisciplinary drug discovery team also leverages the software platform to advance a portfolio of collaborative and proprietary programs to address unmet medical needs.

Founded in 1990, Schrödinger has over 800 employees and is engaged with customers and collaborators in more than 70 countries. To learn more, visit www.schrodinger.com, follow us on LinkedIn and Instagram, or visit our blog, Extrapolations.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230214005003/en/

Jaren Irene Madden (Investors)

Schrödinger, Inc.

jaren.madden@schrodinger.com

617-286-6264

Tracy Lessor (Media)

Schrödinger, Inc.

tracy.lessor@schrodinger.com

617-519-9827

Source: Schrödinger

FAQ

When will Schrödinger report its financial results?

Schrödinger will report its fourth quarter and full-year 2022 financial results on February 28, 2023, after market close.

What time is the Schrödinger conference call?

The conference call will take place at 4:30 p.m. ET on February 28, 2023.

Where can I find the live webcast for Schrödinger's results?

The live webcast can be accessed under 'News & Events' in the investors section of Schrödinger’s website.

What is Schrödinger's business focus?

Schrödinger specializes in a physics-based computational platform for drug and material discovery.